1. Home
  2. NAMS vs TDW Comparison

NAMS vs TDW Comparison

Compare NAMS & TDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • TDW
  • Stock Information
  • Founded
  • NAMS 2019
  • TDW 1956
  • Country
  • NAMS Netherlands
  • TDW United States
  • Employees
  • NAMS N/A
  • TDW N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • TDW Marine Transportation
  • Sector
  • NAMS Health Care
  • TDW Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • TDW Nasdaq
  • Market Cap
  • NAMS 2.5B
  • TDW 2.4B
  • IPO Year
  • NAMS N/A
  • TDW N/A
  • Fundamental
  • Price
  • NAMS $21.13
  • TDW $51.44
  • Analyst Decision
  • NAMS Strong Buy
  • TDW Buy
  • Analyst Count
  • NAMS 8
  • TDW 2
  • Target Price
  • NAMS $42.88
  • TDW $69.00
  • AVG Volume (30 Days)
  • NAMS 1.0M
  • TDW 1.0M
  • Earning Date
  • NAMS 08-06-2025
  • TDW 08-05-2025
  • Dividend Yield
  • NAMS N/A
  • TDW N/A
  • EPS Growth
  • NAMS N/A
  • TDW 32.96
  • EPS
  • NAMS N/A
  • TDW 3.34
  • Revenue
  • NAMS $47,140,000.00
  • TDW $1,358,115,000.00
  • Revenue This Year
  • NAMS N/A
  • TDW $0.68
  • Revenue Next Year
  • NAMS N/A
  • TDW $6.20
  • P/E Ratio
  • NAMS N/A
  • TDW $15.52
  • Revenue Growth
  • NAMS 586.97
  • TDW 19.34
  • 52 Week Low
  • NAMS $14.06
  • TDW $31.17
  • 52 Week High
  • NAMS $27.29
  • TDW $108.44
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 64.57
  • TDW 73.04
  • Support Level
  • NAMS $17.97
  • TDW $47.00
  • Resistance Level
  • NAMS $20.05
  • TDW $48.84
  • Average True Range (ATR)
  • NAMS 0.91
  • TDW 1.82
  • MACD
  • NAMS 0.22
  • TDW 0.31
  • Stochastic Oscillator
  • NAMS 98.59
  • TDW 88.42

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About TDW Tidewater Inc.

Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.

Share on Social Networks: